About
Oliver Maddocks, PhD, is a cancer-metabolism scientist and biotechnology founder. He co-founded Faeth Therapeutics in 2019 and serves as its Chief Scientific Officer; after Faeth's February 2026 acquisition by Sensei Biotherapeutics, Faeth's program became the combined company's lead clinical program. AgFunder also identifies him as a Cancer Research UK Research Fellow and Group Leader at the University of Glasgow Institute of Cancer Sciences.
Areas of interest
biotechoncologycancer metabolismmetabolic therapeuticsprecision medicinenutrition and metabolism